AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV) Stock Price: $225.42+2.35 (+1.05%)
The total return cagr for AbbVie Inc. (ABBV) stock is 23.10% over the past 12 months. The 3 year average growth rate is 22.04% and the 5 year cagr is 19.01%. Total return includes dividends reinvested.
The closing share price for AbbVie Inc. (ABBV) stock was $225.42 for Tuesday, June 9, 2026, up +1.05% from the previous day.
ABBV Price Chart
End-of-day pricesAdvanced chart →
ABBV$225.42▲ 17.15%as of Jun 9, 2026
ABBV Key Metrics
See All MetricsABBV Earnings Preview
Next Earnings Date
Jul 30, 2026
51 days away
EPS Estimate
3.77
Revenue Est.
$16.78B
Last Quarter Results
EPS
$2.65
vs Estimate
$2.67
Met
Revenue
$15.00B
vs Estimate
$14.72B
Beat
ABBV Analyst Ratings
Consensus Rating
Buy
Based on 29 analysts
Strong Buy
8
Buy
16
Hold
8
Sell
0
Strong Sell
0
Average Price Target
$253.55
+12.5% upside
Low
$184.00
Current
$225.42
High
$328.00
ABBV Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $3.27 | N/A | 5 |
| Q2 2027 | N/A | $4.08 | N/A | 5 |
| Q3 2027 | N/A | $4.21 | N/A | 5 |
| Q4 2027 | N/A | $4.41 | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $16.27 | N/A | 18 |
| FY 2028 | N/A | $17.96 | N/A | 13 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $15.93B | N/A | 5 |
| Q2 2027 | N/A | $18.00B | N/A | 5 |
| Q3 2027 | N/A | $18.60B | N/A | 5 |
| Q4 2027 | N/A | $19.41B | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $72.70B | N/A | 18 |
| FY 2028 | N/A | $77.95B | N/A | 13 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
ABBV Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1ABBV | $398.27B | $225.42 | +1.05% | +23.10% | +19.01% | +18.82% |
ABBV Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt